Dr. Kendrith M. Rowland Jr., MD
- Medicare services, 2024
- 800
- Medicare patients, 2024
- 251
- Part D claims, 2024
- 2,738
- Publications
- 27
- Clinical trials
- 10
- Practice address
- 611 West Park Street, Urbana, IL 61801
- Practice phone
- Call (217) 383-3311
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Rowland's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Kendrith M. Rowland Jr. is a medical oncologist in Urbana, Illinois
Dr. Rowland practices at Carle Foundation Hospital in Urbana, Illinois, part of The Carle Foundation.
Dr. Rowland's NPI, 1407955206, was assigned on September 21, 2006. Dr. Rowland graduated from University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) in 1980. Dr. Rowland holds Illinois license 036063711.
- NPI
- 1407955206NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2163589748
- NPI enumeration date
- September 21, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (217) 383-3311
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 72
- Medical school graduation
- 1980
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Kendrith M. Rowland Jr. practices at Carle Foundation Hospital in Urbana, Illinois
Dr. Rowland's primary practice is Carle Foundation Hospital, at 611 West Park Street, Urbana, IL 61801 in Champaign County. The practice phone is (217) 383-3311.
- Carle Foundation Hospital611 West Park Street, Urbana, IL 61801 · Champaign CountyPhone(217) 383-3311
Source: Dmand AI Affiliation Data
Dr. Kendrith M. Rowland Jr. is affiliated with 5 sites of care and 1 medical group
Dr. Rowland's primary practice is Carle Foundation Hospital in Urbana, Illinois, part of The Carle Foundation. Dr. Rowland is also affiliated with Kirby Medical Center. The medical group on file is Carle Physician Group. Dmand AI also links Dr. Rowland to 1 more hospital, 1 group practice or clinic and 1 hospice, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Kendrith M. Rowland Jr.'s practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rowland practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Carle Foundation Hospital | Available with a free account |
| +4 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across The Carle Foundation and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Kendrith M. Rowland Jr. is one of 153 medical oncologists in Illinois
Medical oncology is Dr. Rowland's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Rowland is licensed in Illinois.
Specialties and state licenses
- Medical oncology, IllinoisPrimary
Medical oncologists near Dr. Rowland
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Kendrith M. Rowland Jr. billed Medicare for 800 services in 2024
CMS data shows 800 Medicare services from Dr. Rowland across 4 procedure codes in 2024, for 251 Medicare patients. Medicare paid $50,590 for them.
Dr. Rowland's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 8992024: 80011%
Where Dr. Rowland's Medicare services took place, 2024
- In an office405%
- In a facility76095%
Dr. Rowland compared with the Illinois median for medical oncologists, 2024
- Dr. Rowland
- Illinois median
- Medicare services
- 800vs 67119% above
- Medicare patients
- 251vs 2309% above
- Part D claims
- 2,406vs 3457.0 times
Medians across 140 medical oncologists in Illinois with Dmand AI profiles that report each measure.
Dr. Rowland's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Rowland?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Rowland and other medical oncologists in Illinois.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Kendrith M. Rowland Jr. treated 251 Medicare patients in 2024, average age 73
CMS counts 251 Medicare patients who saw Dr. Rowland in 2024. The largest group is 65 to 74, with 119 patients. 75% of them have cancer, and 71% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Rowland's median patient age at 73, with 76% women.
Dr. Rowland's Medicare patients by age, 2024
Dr. Rowland's Medicare patients by sex, 2024
- Women19076%
- Men6124%
Chronic conditions among Dr. Rowland's Medicare patients, 2024
- Cancer75%
- High blood pressure71%
- High cholesterol68%
- Arthritis40%
- Diabetes29%
- Anxiety28%
- Chronic kidney disease24%
- Ischemic heart disease24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Rowland's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women76%
- Men24%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Kendrith M. Rowland Jr. wrote 2,738 Medicare Part D claims in 2024
In 2024, Dr. Rowland wrote 2,738 Medicare Part D claims for 424 patients. 88% of them were for generic drugs. CMS names the drug for 2,406 of them, across 52 drugs with 11 or more claims each, at $2,946,469 in total drug cost. In 2023, CMS named 2,737 claims across 58 drugs.
Dr. Rowland's Part D claims by kind of drug, 2024
- Generic2,400 claims88%
- Brand-name and other338 claims12%
Dr. Rowland's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Rowland's Part D claims, 2024
- Opioids5%136 of 2,738 claims
- Antibiotics2%58 of 2,738 claims
- Antipsychotics, patients 65 and over3%76 of 2,738 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2,7372024: 2,40612%
Drugs named by CMS: 52 in 2024, 58 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Kendrith M. Rowland Jr. takes part in Medicare
Dr. Rowland accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Kendrith M. Rowland Jr. has 27 publications on record
Dmand AI links 27 papers to Dr. Rowland, published from 2010 to 2025. 2012 was the busiest year, with 4. The most frequent topics are Breast Neoplasms, Double-Blind Method and Antineoplastic Combined Chemotherapy Protocols. Dr. Rowland has published most often in J Clin Oncol. Dr. Rowland's most frequent co-authors are Charles L. Loprinzi, MD, Daniel Alan Nikcevich and Robert J. Behrens, MD.
Dr. Rowland's papers by year, 2011 to 2025
Topics Dr. Rowland writes about most
- Breast Neoplasms
- Double-Blind Method
- Antineoplastic Combined Chemotherapy Protocols
- Cancer Survivors
- Chemotherapy, Adjuvant
- Adenocarcinoma
- Antibodies, Monoclonal, Humanized
- Bupropion
Dr. Rowland's most frequent co-authors
- Charles L. Loprinzi, MD4 shared papers
- Daniel Alan Nikcevich3 shared papers
- Robert J. Behrens, MD2 shared papers
Recent publications by Dr. Rowland
See who Dr. Rowland researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Rowland works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Kendrith M. Rowland Jr. has worked on 10 clinical trials
Dmand AI links Dr. Rowland to 10 clinical trials, 5 of them phase 3 studies. 10 are still active or recruiting. Conditions studied include Anal Canal Carcinoma, Breast Carcinoma In Situ and Breast Neoplasms. National Cancer Institute (NCI) sponsors the most, 10.
Clinical trials with Dr. Rowland by phase
- NonePhase 1: no trials
- 4Phase 2: 4 trials
- 1Phase 2/3: 1 trial
- 5Phase 3: 5 trials
- NonePhase 4: no trials
Conditions in Dr. Rowland's trials
- Anal Canal Carcinoma
- Breast Carcinoma In Situ
- Breast Neoplasms
- Fallopian Tube Diseases
- Glioblastoma
Investigators on the most trials with Dr. Rowland
- Amy K. Krie, MD4 shared trials
- Ashkan Bahrani, MD3 shared trials
- Gary L. Buchschacher Jr, MD3 shared trials
Recent clinical trials with Dr. Rowland
A Randomized Phase III Study of Immune Checkpoint Inhibition With Chemotherapy in Treatment-Naive Metastatic Anal Cancer Patients (opens in a new tab)
A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden (opens in a new tab)
A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma (opens in a new tab)
Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Kendrith M. Rowland Jr. received $1,991 in industry payments from 2017 to 2025
CMS Open Payments shows 78 general payments to Dr. Rowland from 24 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 80% of the total. AstraZeneca Pharmaceuticals LP paid the most, $321.
General payments to Dr. Rowland by program year, 2017 to 2025
General payments to Dr. Rowland by kind, 2017 to 2025
- Food and beverage$1,58880%
- Education$40320%
Companies that paid Dr. Rowland the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Kendrith M. Rowland Jr. graduated from University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb)
Dr. Rowland graduated from University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) in 1980.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Kendrith M. Rowland Jr.'s profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Kendrith M. Rowland Jr.
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Kendrith M. Rowland Jr.'s NPI number?
Dr. Kendrith M. Rowland Jr.'s NPI number is 1407955206. It was assigned on September 21, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Kendrith M. Rowland Jr.?
Dr. Kendrith M. Rowland Jr. is a medical oncologist in Urbana, Illinois. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Kendrith M. Rowland Jr. practice?
Dr. Rowland practices at 611 West Park Street, Urbana, IL 61801. Dr. Rowland's primary practice is Carle Foundation Hospital in Urbana, Illinois, part of The Carle Foundation. Dmand AI also links Dr. Rowland to 1 hospital, 1 group practice or clinic and 1 hospice.
What is Dr. Kendrith M. Rowland Jr.'s office phone number?
The practice phone on file for Dr. Rowland is (217) 383-3311.
What is Dr. Kendrith M. Rowland Jr.'s medical license number?
Dr. Rowland holds Illinois license 036063711.
Which hospitals is Dr. Kendrith M. Rowland Jr. affiliated with?
Dr. Rowland practices at Carle Foundation Hospital in Urbana, Illinois. Dr. Rowland is also affiliated with Kirby Medical Center. Dmand AI links Dr. Rowland to 1 more hospital.
What medical group is Dr. Kendrith M. Rowland Jr. part of?
Dr. Rowland is linked to Carle Physician Group.
Does Dr. Kendrith M. Rowland Jr. accept Medicare?
Yes. CMS data shows Dr. Rowland billed Medicare for 800 services in 2024, and Dr. Rowland accepts Medicare assignment.
How many Medicare patients does Dr. Kendrith M. Rowland Jr. see?
CMS counts 251 Medicare patients who saw Dr. Rowland in 2024, with an average age of 73.
What services does Dr. Kendrith M. Rowland Jr. bill to Medicare?
In 2024, Dr. Rowland's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99213) and office visit, new patient (99204).
Show 6 more questionsShow fewer questions
Where did Dr. Kendrith M. Rowland Jr. go to medical school?
Dr. Rowland graduated from University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) in 1980.
What drugs does Dr. Kendrith M. Rowland Jr. prescribe most?
In 2024 Medicare Part D data, Dr. Rowland's most prescribed drugs by claims were Tamoxifen Citrate, Letrozole and Ondansetron ODT.
Has Dr. Kendrith M. Rowland Jr. received payments from drug or device companies?
CMS Open Payments shows $1,991 in general payments to Dr. Rowland from 24 companies from 2017 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Kendrith M. Rowland Jr. been practicing?
Dr. Rowland graduated from medical school in 1980, 46 years ago.
Does Dr. Kendrith M. Rowland Jr. do research?
Dmand AI links 27 publications to Dr. Rowland, published from 2010 to 2025. Dr. Rowland has worked on 10 clinical trials.
Who does Dr. Kendrith M. Rowland Jr. publish with?
Dr. Rowland's most frequent co-authors are Charles L. Loprinzi, MD (4 shared papers), Daniel Alan Nikcevich (3 shared papers) and Robert J. Behrens, MD (2 shared papers).
Selling to medical oncology practices?
See medical oncologists in Illinois by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card